- Baltimore MD, US Erin Strickland - Greensboro NC, US Gregory L. McIntire - Greensboro NC, US Ayodele Morris - Midland TX, US
International Classification:
G01N 33/94 H01J 49/00 G01N 33/493
Abstract:
The present disclosure provides methods for monitoring subject (e.g., patient) adherence to lurasidone therapy, for example as a component of treating a subject for a mental health disorder such as schizophrenia.
Methods Of Monitoring Adherence To Haloperidol Therapy
- Baltimore MD, US Oneka Cummings - Greensboro NC, US Gregory L. McIntire - Greensboro NC, US
International Classification:
C12Q 1/40
Abstract:
The present disclosure provides methods for monitoring subject (e.g., patient) adherence to Haldol therapy, for example as a component of treating a subject for a mental health disorder such as schizophrenia.
Methods Of Monitoring Adherence To Lurasidone Therapy
- Baltimore MD, US Erin Strickland - Greensboro NC, US Gregory L. McIntire - Greensboro NC, US Ayodele Morris - Midland TX, US
International Classification:
G01N 33/94 H01J 49/00
Abstract:
The present disclosure provides methods for monitoring subject (e.g., patient) adherence to lurasidone therapy, for example as a component of treating a subject for a mental health disorder such as schizophrenia.
Methods Of Monitoring For Adherence To Aripiprazole Therapy